Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorJimenez Balarezo, Moraima
dc.contributor.authorRoldan Galvan, Elisa
dc.contributor.authorFernandez Naval, Candela
dc.contributor.authorPeralta Garzon, Soraya
dc.contributor.authorPujadas, Gemma
dc.contributor.authorHernández Buñuel, Cristina
dc.contributor.authorGironella Mesa, Mercedes
dc.contributor.authorOrti Pascual, Guillem
dc.contributor.authorBarba Suñol, Pere
dc.contributor.authorPumarola Suñé, Tomàs
dc.contributor.authorCabirta Touzon, Alba
dc.contributor.authorCatalá, Eva
dc.contributor.authorValentin, Mercedes
dc.contributor.authorOrfao, Alberto
dc.contributor.authorGonzález, Marcos
dc.contributor.authorRuiz Camps, Isabel
dc.contributor.authorValcarcel Ferreiras, David
dc.contributor.authorBosch, Francesc
dc.contributor.authorHernández González, Manuel
dc.contributor.authorCrespo Maull, Marta
dc.contributor.authorEsperalba Esquerra, Juliana
dc.contributor.authorVillacampa Javierre, Guillermo
dc.contributor.authorMarin Niebla, Ana
dc.contributor.authorMartínez Gallo, Mónica
dc.contributor.authorFox, Maria Laura
dc.contributor.authorCampins Martí, Magda
dc.contributor.authorAbrisqueta, Pau
dc.contributor.authorMedina-Gil, Daniel
dc.contributor.authorPagès Geli, Carlota
dc.date.accessioned2022-12-09T08:56:25Z
dc.date.available2022-12-09T08:56:25Z
dc.date.issued2022-02-08
dc.identifier.citationJimenez M, Roldan E, Fernandez-Naval C, Villacampa G, Martinez-Gallo M, Medina-Gil D, et al. Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies. Blood Adv. 2022 Feb 8;6(3):774–84.
dc.identifier.issn2473-9537
dc.identifier.urihttps://hdl.handle.net/11351/8614
dc.descriptionImmunobiologia; Immunoteràpia
dc.language.isoeng
dc.publisherAmerican Society of Hematology
dc.relation.ispartofseriesBlood Advances;6(3)
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectCOVID-19 (Malaltia) - Vacunació
dc.subjectImmunoglobulines
dc.subjectSang - Malalties
dc.subject.meshHematologic Neoplasms
dc.subject.meshCoronavirus Infections
dc.subject.meshImmunogenicity, Vaccine
dc.titleCellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1182/bloodadvances.2021006101
dc.subject.decsneoplasias hematológicas
dc.subject.decsinfecciones por Coronavirus
dc.subject.decsinmunogenicidad vacunal
dc.relation.publishversionhttps://doi.org/10.1182/bloodadvances.2021006101
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Jiménez M, Roldán E, Gironella M, Fox L, Orti G, Barba P, Valcárcel D, Bosch F, Abrisqueta P] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Fernández-Naval C, Pumarola T, Esperalba J] Servei de Microbiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Villacampa G] Oncology Data Science (ODysSey) Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Martinez-Gallo M, Hernández M] Servei d’Immunologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Departament de Biologia Cel·lular, Fisiologia i Immunologia, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Medina-Gil D, Peralta-Garzón S, Pujadas G, Hernández C, Pagès C, Crespo M] Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Cabirta A, Catalá E, Valentín M, Marín-Niebla A] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Orfao A] Department of Medicine and Cytometry General ServiceNucleus, Cancer Research Centre (IBMCC/CSIC/USAL/IBSAL), Salamanca, Spain. [González M] Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC–CB16/12/00233 and Center for Cancer Research–IBMCC (USAL-CSIC), Salamanca, Spain. [Campins M] Servei de Medicina Preventiva i Epidemiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Ruiz-Camps I] Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain
dc.identifier.pmid34844263
dc.identifier.wos000754263400007
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Portada del document

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple